Cargando…
Single-dose application of antithrombin III as alternative anticoagulation during extracorporeal therapy in critically ill patients with advanced liver cirrhosis: a retrospective data analysis
Autores principales: | Brunner, R, Madl, C, Druml, W, Holzinger, U |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061753/ http://dx.doi.org/10.1186/cc9543 |
Ejemplares similares
-
Impact of real-time continuous glucose monitoring on glucose variability in critically ill patients
por: Brunner, R, et al.
Publicado: (2010) -
Early treatment with intravenous immunoglobulins in patients with critical illness polyneuropathy: a randomized controlled, double-blinded study
por: Brunner, R, et al.
Publicado: (2012) -
Antithrombin III concentrate therapy may have an efficacy in sepsis
por: Saito, N, et al.
Publicado: (2013) -
Antithrombin III concentrate may contribute to sepsis in nonovert disseminated intravascular coagulation
por: Saito, Noriko, et al.
Publicado: (2013) -
Autopsy-detected diagnostic errors in critically ill patients with cirrhosis
por: De Mey, N, et al.
Publicado: (2014)